Innovent is a leading biotech company in China with strong roots in oncology, anchored by its core PD-1 drug Tyvyt. The price cut for PD-1 drugs has stabilized gradually. Hence, we expect stable ...

VetStem, Inc. has secured funding for final development work on StemStatTM Ortho for conditional approval submission to the FDA CVM. This additional funding allows us to finalize the regulatory ...

A revolutionary new pill designed to extend the lifespan of dogs has received key regulatory approval from the U.S. Food and ...

In this opinion piece, Austin Therrell, executive director of the Association of American Feed Control Officials, argues that state regulators have a timely solution for addressing the need to reform ...

Dogs that have oral squamous cell carcinomas often need surgery that disfigures their jaws and lower their quality of ...

SAN FRANCISCO--(BUSINESS WIRE)--Loyal, a clinical-stage animal health company developing longevity drugs for dogs, announced today that the FDA’s Center for Veterinary Medicine has accepted the ...

CEL-SCI (CVM) announced that a third-party study published on March 6 in JAMA Oncology provided data that support Multikine’s use as a ...

Three U.S. senators are calling on Robert Kennedy Jr. to disclose what he and President Trump discussed with drugmakers ...

A New Preventive Paradigm The FDA's Center for Veterinary Medicine has determined that Loyal's data provides reasonable expectation of LOY-002's intended effect of extending canine lifespan ...

The drug substantially inhibited the growth of the ... associate professor of dentistry and oral surgery in the College of Veterinary Medicine (CVM) and senior author of the study, published ...

FDA could allow the drug into the market, as soon as next year, once Loyalhits certain safety and manufacturing milestones.

Watching dogs grow and get older is a bittersweet experience, but what if there was a way we could give our canine companions longer, healthier lives? Well, that reality just came one step closer ...